Skip to content

Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06171932
Enrollment
60
Registered
2023-12-15
Start date
2023-11-26
Completion date
2024-08-08
Last updated
2023-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Acute

Brief summary

COMPARISON OF EFFICACY OF HYDROCORTISONE AND METHYLPREDNISOLONE IN ACUTE SEVERE ASTHMA In this study Investigator will compare the efficacy of hydrocortisone and methyl prednisolone in acute severe asthma that will lead to final result and beneficial effects that will help in early resoloution of symptoms and help in preventing recurrence

Detailed description

investigator will compare the efficacy of hydrocortisone v/s methylprednisolone in management of patients presented with acute severe asthma in emergency. A local study was conducted in 2009, after that there is a big research gap exists at national level although international literature is available on the same but it can not be generalized to our population due to socio, geographic and economic differences so there is dire need to conduct this study this gives a strong rationale to implement in our settings

Interventions

DRUGMethylprednisolone,

No intervention required

Sponsors

University of Karachi
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years

Inclusion criteria

* Either Gender (18 to 50 years old) * Patient presenting to emergency department with acute severe asthma

Exclusion criteria

* Patients with critical illness or pregnant females. .Patient treated other than hydrocortisone and methylprednisolone. .Patients not willing to participate in study. * Life threatening asthma * Near fatal asthm

Design outcomes

Primary

MeasureTime frameDescription
Spirometry24 hoursAbove will be check on arrival of patient to Emergency and post Managment
Blood pressures24 hoursVital signs at initial presentation and post managment will be recorded Blood pressure in mm HG will be recorded
Respiratory rate24 hoursRespiratory rate at arrival and post managment will be considered Respiratory rate in Breaths/min
Heart rate24 hoursHeart rate beats/min will be checked
PEAK EXPIRATORY FLOW RATE24 hoursit wil be checked on arrival and post managment in Peak Expiratory Flow rate (force expiratory volume in 1 second and force vital capacity )will be examined

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026